Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796635 · ClinicalTrials.gov registry record · NA
An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores
A NA study, sponsored by Focus Consumer Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05796635: Completed NA study, sponsored by Focus Consumer Healthcare.
NCT05796635 is a NA study that has completed, run by Focus Consumer Healthcare. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05796635, a NA study, has completed, sponsored by Focus Consumer Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.
Primary Outcome
Cold sore severity will be measured via survey and cold sore severity grading. Symptom severity is rated on a scale of 0 (Not a problem) to 6 (Severe)
Interventions
- OTHER Herpecin L
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-01-04 |
| Est. Completion | 2023-02-20 |
| Phase | NA |
What the finished NCT05796635 record still lists
NCT05796635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Herpecin L is the first listed.
NCT05796635 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05796635 about?
NCT05796635 is a clinical study titled "An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores". Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.
What is the current status of trial NCT05796635?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-01-04. Estimated completion is 2023-02-20.
What interventions are being tested in trial NCT05796635?
The interventions under investigation include: Herpecin L (OTHER).
Who is sponsoring clinical trial NCT05796635?
This trial is sponsored by Focus Consumer Healthcare, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05796635's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI